AVANT BIO

New York, New York
Firm Location:New York, New York • United Kingdom
AVANT BIO Team
Photo of Jessica Davis, Principal at AVANT BIO
Jessica Davis
AVANT BIO·Principal
Sweet spot: $15.0M
Range: $1M - $50.0M
Investors in New York (NY)
Investors in BioTech (Series A), Investors in Consumer Health (Seed), Investors in Consumer Health (Series B), Investors in Consumer Health (Series A), Investors in BioTech (Series B), Investors in Health IT (Series B), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in Health IT (Series A), Investors in Consumer Health (Seed), Investors in Health IT (Seed), Investors in BioTech (Series A), Investors in Consumer Health (Series A), Investors in Health IT (Series A), Investors in BioTech (Series B), Investors in Consumer Health (Series B), Investors in Health IT (Series B), Investors in Diagnostics (Series A), Investors in Diagnostics (Seed), Investors in Diagnostics (Series B), Investors in Digital Health (Seed), Investors in Diagnostics (Series B), Investors in Diagnostics (Seed), Investors in Diagnostics (Series A), Investors in Digital Health (Series A), Investors in Digital Health (Series A), Investors in Digital Health (Series B), Investors in Digital Health (Seed), Investors in Digital Health (Series B), Investors in BioTech (Seed), Investors in New York City (Other Lists)
Photo of Ole Henrik Bang-Andreasen, Analyst at AVANT BIO
Ole Henrik Bang-Andreasen
AVANT BIO·Analyst
Sweet spot: $15.0M
Range: $1M - $50.0M
Investors in United Kingdom
Investors in BioTech (Series A), Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Series B), Investors in Therapeutics (Series A), Investors in BioTech (Series B), Investors in Medical Devices (Series B), Investors in Medical Devices (Series A), Investors in Health IT (Series B), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in Diagnostics (Seed), Investors in Diagnostics (Series B), Investors in Diagnostics (Series A), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Digital Health (Series B), Investors in Therapeutics (Seed), Investors in Therapeutics (Series B), Investors in Medical Devices (Seed), Investors in Health IT (Series A)
Photo of Peter Lee, Partner at AVANT BIO
Peter Lee
AVANT BIO·Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in New York (NY)